Karpus Investment Management’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.52M | Sell |
430,720
-36,971
| -8% | -$474K | 0.18% | 116 |
|
|
2025
Q1 | $5.93M | Sell |
467,691
-21,881
| -4% | -$278K | 0.19% | 117 |
|
|
2024
Q4 | $6.42M | Buy |
489,572
+20,974
| +4% | +$275K | 0.19% | 106 |
|
|
2024
Q3 | $7.07M | Buy |
468,598
+64,214
| +16% | +$968K | 0.2% | 106 |
|
|
2024
Q2 | $5.73M | Buy |
404,384
+58,866
| +17% | +$834K | 0.16% | 102 |
|
|
2024
Q1 | $4.71M | Buy |
+345,518
| New | +$4.71M | 0.14% | 115 |
|
|
2020
Q3 | – | Sell |
-65,215
| Closed | -$1.17M | – | 214 |
|
|
2020
Q2 | $1.17M | Sell |
65,215
-72,340
| -53% | -$1.3M | 0.04% | 149 |
|
|
2020
Q1 | $2.06M | Buy |
137,555
+1,990
| +1% | +$29.8K | 0.08% | 132 |
|
|
2019
Q4 | $2.36M | Buy |
+135,565
| New | +$2.36M | 0.08% | 128 |
|
|
2014
Q3 | – | Sell |
-17,500
| Closed | -$363K | – | 184 |
|
|
2014
Q2 | $363K | Buy |
+17,500
| New | +$363K | 0.02% | 154 |
|